Cochrane Abstracts
Hydroxyurea for reducing blood transfusion in non‐transfusion dependent beta thalassaemias
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Hydroxyurea for Reducing Blood Transfusion in Non‐transfusion Dependent Beta Thalassaemias." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439115/all/Hydroxyurea_for_reducing_blood_transfusion_in_non‐transfusion_dependent_beta_thalassaemias.
Hydroxyurea for reducing blood transfusion in non‐transfusion dependent beta thalassaemias. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439115/all/Hydroxyurea_for_reducing_blood_transfusion_in_non‐transfusion_dependent_beta_thalassaemias. Accessed March 22, 2025.
Hydroxyurea for reducing blood transfusion in non‐transfusion dependent beta thalassaemias. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439115/all/Hydroxyurea_for_reducing_blood_transfusion_in_non‐transfusion_dependent_beta_thalassaemias
Hydroxyurea for Reducing Blood Transfusion in Non‐transfusion Dependent Beta Thalassaemias [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439115/all/Hydroxyurea_for_reducing_blood_transfusion_in_non‐transfusion_dependent_beta_thalassaemias.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Hydroxyurea for reducing blood transfusion in non‐transfusion dependent beta thalassaemias
ID - 439115
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439115/all/Hydroxyurea_for_reducing_blood_transfusion_in_non‐transfusion_dependent_beta_thalassaemias
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
